ES2076358T3 - Granulados con elevado contenido de ibuprofeno. - Google Patents

Granulados con elevado contenido de ibuprofeno.

Info

Publication number
ES2076358T3
ES2076358T3 ES90902888T ES90902888T ES2076358T3 ES 2076358 T3 ES2076358 T3 ES 2076358T3 ES 90902888 T ES90902888 T ES 90902888T ES 90902888 T ES90902888 T ES 90902888T ES 2076358 T3 ES2076358 T3 ES 2076358T3
Authority
ES
Spain
Prior art keywords
binder
percent
polyvinylpyrrolidone
granulates
ibuprofen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90902888T
Other languages
English (en)
Inventor
Larry E Denton
Anil M Salpekar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mallinckrodt Inc
Original Assignee
Mallinckrodt Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Inc filed Critical Mallinckrodt Inc
Application granted granted Critical
Publication of ES2076358T3 publication Critical patent/ES2076358T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

SE DESCRIBE UNA COMPOSICION FARMACEUTICA GRANULAR QUE CONTIENE IBUPROFENO EN UNA PROPORCION DE 85 A 99%, UN AGLOMERANTE EN UNA PROPORCION DE 0.9 A 15%, Y POLIVINIPIRROLIDONA, DONDE LA POLIVINILPIRROLIDONA FORMA UNA PELICULA CON UNA PARTE DE DICHO AGLOMERANTE PARA FORMAR AGLOMERADOS. EL IBUPROFENO PUEDE FLUDIZARSE CON UNA PARTE DEL AGLOMERANTE EN UN APARATO DE LECHO FLUIDO Y PULVERIZADO CON UNA DISPERSION ACUOSA DE POLIVINILPIRROLIDONA Y EL RESTO DEL AGLOMERANTE. ESTA GRANULACION PUEDE MEZCLARSE DESPUES CON EXCIPIENTES ADICIONALES, Y, OPCIONALMENTE, INGREDIENTES FARMACEUTICOS ACTIVOS ADICIONALES PARA LA COMPRESION DIRECTA EN TABLETAS.
ES90902888T 1989-02-02 1990-01-31 Granulados con elevado contenido de ibuprofeno. Expired - Lifetime ES2076358T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/306,014 US4911921A (en) 1989-02-02 1989-02-02 High ibuprofen content granulations

Publications (1)

Publication Number Publication Date
ES2076358T3 true ES2076358T3 (es) 1995-11-01

Family

ID=23183358

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90902888T Expired - Lifetime ES2076358T3 (es) 1989-02-02 1990-01-31 Granulados con elevado contenido de ibuprofeno.

Country Status (10)

Country Link
US (1) US4911921A (es)
EP (1) EP0456720B1 (es)
JP (1) JP2556623B2 (es)
AT (1) ATE124257T1 (es)
AU (1) AU629913B2 (es)
CA (1) CA2045680C (es)
DE (1) DE69020541T2 (es)
DK (1) DK0456720T3 (es)
ES (1) ES2076358T3 (es)
WO (1) WO1990008542A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5104648A (en) * 1989-02-02 1992-04-14 Mallinckrodt Specialty Chemicals Company High ibuprofen content granulations
US5087454A (en) * 1990-07-30 1992-02-11 American Home Products Corporation Ibuprofen tablet
GB9119052D0 (en) * 1991-09-06 1991-10-23 Boots Co Plc Pharmaceutical compositions
US5191114A (en) * 1991-10-09 1993-03-02 Sage Pharmaceuticals, Inc. Process for enhancing the flow characteristics of ibuprofen
US5310961A (en) * 1993-07-02 1994-05-10 Affinity Biotech, Inc. Neomorphic ibuprofen
US6348216B1 (en) * 1996-06-10 2002-02-19 Knoll Pharmaceutical Company Ibuprofen and narcotic analgesic compositions
US6361794B1 (en) 1996-06-12 2002-03-26 Basf Corporation Method of making ibuprofen and narcotic analgesic composition
US5837292A (en) * 1996-07-03 1998-11-17 Yamanouchi Europe B.V. Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug
FR2772617B1 (fr) * 1997-12-19 2001-03-09 Besins Iscovesco Lab Comprime de progesterone et son procede de preparation
IT1301966B1 (it) 1998-07-30 2000-07-20 Zambon Spa Composizioni farmaceutiche ad attivita' analgesica
US6251945B1 (en) 1999-01-14 2001-06-26 Knoll Aktiengesellschaft Pharmaceutical mixture comprising a combination of a profen and other active compounds
DE10003757A1 (de) * 2000-01-28 2001-08-02 Knoll Ag Ibuprofen-Wirkstoffzubereitung
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
SK50232004A3 (sk) † 2002-04-29 2005-04-01 Egis Gy�Gyszergy�R Rt. Spôsob prípravy tabliet z farmaceuticky aktívnych látok, ktoré majú nevýhodné tabletačné vlastnosti s granulačnou kvapalinou obsahujúcou mikrokryštalickú celulózu
US20040253308A1 (en) * 2003-04-29 2004-12-16 Barr Laboratories, Inc. Surface-treated modafinil particles
MXPA06015027A (es) * 2004-06-30 2007-02-08 Albemarle Corp Granulos de alto contenido de ibuprofeno y su preparacion y su uso en formas de dosificacion farmaceutica.
ATE512961T1 (de) 2004-07-30 2011-07-15 Torrent Pharmaceuticals Ltd Amorphes nebivolol hydrochlorid und seine herstellung
PT1884242E (pt) 2005-05-26 2013-05-21 Dainippon Sumitomo Pharma Co Composição farmacêutica compreendendo lurasidona
CA2577760A1 (en) * 2006-02-27 2007-08-27 Tyco Healthcare Group Lp Pressurized dip coating system
US20080069889A1 (en) * 2006-03-07 2008-03-20 Cherukuri S R Compressible resilient granules and formulations prepared therefrom
US20070212417A1 (en) * 2006-03-07 2007-09-13 Cherukuri S R Compressible resilient granules and formulations prepared therefrom

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3108046A (en) * 1960-11-25 1963-10-22 Smith Kline French Lab Method of preparing high dosage sustained release tablet and product of this method
US4209513A (en) * 1974-02-14 1980-06-24 Burroughs Wellcome Co. Tablet formulation
US4661521A (en) * 1984-04-30 1987-04-28 Mallinckrodt, Inc. Direct tableting acetaminophen compositions
US4609675A (en) * 1984-08-17 1986-09-02 The Upjohn Company Stable, high dose, high bulk density ibuprofen granulations for tablet and capsule manufacturing
US4753801A (en) * 1985-10-25 1988-06-28 Eli Lilly And Company Sustained release tablets
US4757090A (en) * 1986-07-14 1988-07-12 Mallinckrodt, Inc. Direct tableting acetaminophen compositions
US4806359A (en) * 1987-04-22 1989-02-21 Mcneilab, Inc. Iburprofen sustained release matrix and process
US4837031A (en) * 1987-09-17 1989-06-06 Mallinckrodt, Inc. Compositions containing ibuprofen

Also Published As

Publication number Publication date
DE69020541D1 (de) 1995-08-03
JPH04503069A (ja) 1992-06-04
AU629913B2 (en) 1992-10-15
CA2045680A1 (en) 1990-08-03
JP2556623B2 (ja) 1996-11-20
WO1990008542A1 (en) 1990-08-09
CA2045680C (en) 1997-01-14
EP0456720B1 (en) 1995-06-28
AU5036990A (en) 1990-08-24
DK0456720T3 (da) 1995-08-14
US4911921A (en) 1990-03-27
EP0456720A1 (en) 1991-11-21
ATE124257T1 (de) 1995-07-15
DE69020541T2 (de) 1995-11-02

Similar Documents

Publication Publication Date Title
ES2076358T3 (es) Granulados con elevado contenido de ibuprofeno.
DE69203488T2 (de) Niedrigdosierte getrocknete pharmazeutische Präparate.
DK0560092T3 (da) Tabletter, granulater og pellets med højt indholdaf aktivstoffer til højkoncentrerede, faste administreringsformer
DE3877764T2 (de) Ein freifliessendes granulat, enthaltend ibuprofen und ein herstellunsgverfahren.
TR200200688T2 (tr) Doğrudan tablet şeklinde preslenebilen ultra ince asetaminofen terkipleri ve bu terkiplerin üretim prosesi
ATE86479T1 (de) Pharmazeutische matrix mit verzoegerter freisetzung und verfahren.
UA5328A1 (uk) Спосіб одержання таблеток
PH25173A (en) Pharmaceutical composition
NZ218734A (en) Tablets containing coated microspheres which contain ibuprofen (2-(4-isobutyl phenyl)propanoic acid)
GR900300172T1 (en) Processes for the preparation of pharmaceutical compositions containing bromocriptine having high stability and related products
JPS5726615A (en) Improving method for absorbability of slightly soluble drug
ES2093192T3 (es) Formulacion farmaceutica con elevado contenido de lisinato de ibuprofeno.
JPS5781409A (en) External plaster
ES2154744T3 (es) Formulaciones de comprimidos farmaceuticos para compresion directa.
Hontz Assessment of Selected formulation and processing variables in fluid bed granulation
TH13475A (th) สูตรผสมทางเภสัชกรรม
JPS57112328A (en) Hypotensor comprising 2,3-dihydroxypropyl ester of n-(7- chloro-4-quinolyl)anthranillic acid

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 456720

Country of ref document: ES